212 related articles for article (PubMed ID: 37870957)
1. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
Li X; Moon G; Shin S; Zhang B; Janknecht R
Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
[TBL] [Abstract][Full Text] [Related]
5. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
Kim TD; Shin S; Janknecht R
Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
[TBL] [Abstract][Full Text] [Related]
6. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
Berry WL; Shin S; Lightfoot SA; Janknecht R
Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
Kim TD; Gu R; Janknecht R
Int J Biochem Mol Biol; 2023; 14(6):101-115. PubMed ID: 38213775
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
Kim TD; Oh S; Lightfoot SA; Shin S; Wren JD; Janknecht R
Int J Clin Exp Med; 2016; 9(6):10123-10134. PubMed ID: 28883898
[TBL] [Abstract][Full Text] [Related]
10. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites.
Mallette FA; Mattiroli F; Cui G; Young LC; Hendzel MJ; Mer G; Sixma TK; Richard S
EMBO J; 2012 Apr; 31(8):1865-78. PubMed ID: 22373579
[TBL] [Abstract][Full Text] [Related]
11. Engineering human JMJD2A tudor domains for an improved understanding of histone peptide recognition.
Parkinson J; Hard R; Ainsworth R; Wang W
Proteins; 2023 Jan; 91(1):32-46. PubMed ID: 35927178
[TBL] [Abstract][Full Text] [Related]
12. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
[TBL] [Abstract][Full Text] [Related]
13. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
14. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice.
Zhang QJ; Chen HZ; Wang L; Liu DP; Hill JA; Liu ZP
J Clin Invest; 2011 Jun; 121(6):2447-56. PubMed ID: 21555854
[TBL] [Abstract][Full Text] [Related]
15. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
Mallette FA; Richard S
Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
[TBL] [Abstract][Full Text] [Related]
16. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein.
Van Rechem C; Black JC; Abbas T; Allen A; Rinehart CA; Yuan GC; Dutta A; Whetstine JR
J Biol Chem; 2011 Sep; 286(35):30462-30470. PubMed ID: 21757720
[TBL] [Abstract][Full Text] [Related]
17. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
Oh S; Shin S; Janknecht R
Int J Clin Exp Pathol; 2021; 14(7):795-810. PubMed ID: 34367411
[TBL] [Abstract][Full Text] [Related]
19. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Kauffman EC; Robinson BD; Downes MJ; Powell LG; Lee MM; Scherr DS; Gudas LJ; Mongan NP
Mol Carcinog; 2011 Dec; 50(12):931-44. PubMed ID: 21400613
[TBL] [Abstract][Full Text] [Related]
20. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A.
Huang Y; Fang J; Bedford MT; Zhang Y; Xu RM
Science; 2006 May; 312(5774):748-51. PubMed ID: 16601153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
